{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:25:17Z","timestamp":1793831117927,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Res"],"DOI":"10.1038\/s41422-026-01293-x","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:22:01Z","timestamp":1790745721000},"page":"874-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ursodeoxycholic acid enhances cancer radioimmunotherapy by releasing a human-biased FXR-TRIM22-STAT1 immune brake"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0710-0293","authenticated-orcid":false,"given":"Xinyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7174-5366","authenticated-orcid":false,"given":"Somaira","family":"Nowsheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6812-9917","authenticated-orcid":false,"given":"Nan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8483-4616","authenticated-orcid":false,"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1938-3091","authenticated-orcid":false,"given":"Zhenkun","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1987-9775","authenticated-orcid":false,"given":"Min","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"1293_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005248","volume":"10","author":"LL van der Woude","year":"2022","unstructured":"van der Woude, L. L. et al. Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination. J. Immunother. Cancer 10, e005248 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"1293_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","volume":"7","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z., Liu, X., Chen, D. & Yu, J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct. Target. Ther. 7, 258 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1293_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1056\/NEJMoa1112824","volume":"366","author":"MA Postow","year":"2012","unstructured":"Postow, M. A. et al. Immunologic correlates of the abscopal effect in a patient with melanoma.  N. Engl. J. Med. 366, 925\u2013931 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1293_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature23470","volume":"548","author":"SM Harding","year":"2017","unstructured":"Harding, S. M. et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548, 466\u2013470 (2017).","journal-title":"Nature"},{"key":"1293_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","volume":"39","author":"ME Rodr\u00edguez-Ruiz","year":"2018","unstructured":"Rodr\u00edguez-Ruiz, M. E., Vanpouille-Box, C., Melero, I., Formenti, S. C. & Demaria, S. Immunological mechanisms responsible for radiation-induced abscopal effect. Trends Immunol. 39, 644\u2013655 (2018).","journal-title":"Trends Immunol."},{"key":"1293_CR6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jtho.2017.04.014","volume":"12","author":"X Gong","year":"2017","unstructured":"Gong, X. et al. Combined radiotherapy and anti-PD-L1 antibody synergistically enhances antitumor effect in non-small cell lung cancer. J. Thorac. Oncol. 12, 1085\u20131097 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"1293_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-023-01462-z","volume":"8","author":"S Guo","year":"2023","unstructured":"Guo, S. et al. Radiation-induced tumor immune microenvironments and potential targets for combination therapy. Signal Transduct. Target. Ther. 8, 205 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1293_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","volume":"12","author":"FG Herrera","year":"2022","unstructured":"Herrera, F. G. et al. Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy. Cancer Discov. 12, 108\u2013133 (2022).","journal-title":"Cancer Discov."},{"key":"1293_CR9","doi-asserted-by":"crossref","unstructured":"Storozynsky, Q. & Hitt, M. M. The impact of radiation-induced DNA damage on cGAS\u2013STING-mediated immune responses to cancer. Int. J. Mol. Sci. 21, 8877 (2020).","DOI":"10.3390\/ijms21228877"},{"key":"1293_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout, A., Katz, J. D., Venkatraman, S. & Ablasser, A. The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548\u2013569 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1293_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf6290","volume":"7","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation. Sci. Adv. 7, eabf6290 (2021).","journal-title":"Sci. Adv."},{"key":"1293_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36523-y","volume":"14","author":"JY Li","year":"2023","unstructured":"Li, J. Y. et al. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models. Nat. Commun. 14, 865 (2023).","journal-title":"Nat. Commun."},{"key":"1293_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307858","volume":"11","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. STING agonist-loaded nanoparticles promotes positive regulation of type I interferon-dependent radioimmunotherapy in rectal cancer. Adv. Sci. 11, e2307858 (2024).","journal-title":"Adv. Sci."},{"key":"1293_CR14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1084\/jem.20180139","volume":"215","author":"T Li","year":"2018","unstructured":"Li, T. & Chen, Z. J. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer.  J. Exp. Med. 215, 1287\u20131299 (2018).","journal-title":"J. Exp. Med."},{"key":"1293_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","volume":"36","author":"GR Stark","year":"2012","unstructured":"Stark, G. R. & Darnell, J. E. Jr The JAK-STAT pathway at twenty. Immunity 36, 503\u2013514 (2012).","journal-title":"Immunity"},{"key":"1293_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1158\/2159-8290.CD-19-0608","volume":"10","author":"JB Fan","year":"2020","unstructured":"Fan, J. B. et al. Type I interferon regulates a coordinated gene network to enhance cytotoxic T cell-mediated tumor killing. Cancer Discov. 10, 382\u2013393 (2020).","journal-title":"Cancer Discov."},{"key":"1293_CR17","doi-asserted-by":"crossref","unstructured":"Huang, K. C. et al. Colorectal cancer-specific IFN\u03b2 delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy. J. Iimmunother. Cancer 12, e008515 (2024).","DOI":"10.1136\/jitc-2023-008515"},{"key":"1293_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01247-w","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. cGAS\u2013STING pathway in cancer biotherapy. Mol. Cancer 19, 136 (2020).","journal-title":"Mol. Cancer"},{"key":"1293_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/cac2.12539","volume":"44","author":"GR Khosravi","year":"2024","unstructured":"Khosravi, G. R. et al. Immunologic tumor microenvironment modulators for turning cold tumors hot. Cancer Commun. 44, 521\u2013553 (2024).","journal-title":"Cancer Commun."},{"key":"1293_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.trecan.2016.09.007","volume":"2","author":"W Jiang","year":"2016","unstructured":"Jiang, W., Chan, C. K., Weissman, I. L., Kim, B. Y. S. & Hahn, S. M. Immune priming of the tumor microenvironment by radiation. Trends Cancer 2, 638\u2013645 (2016).","journal-title":"Trends Cancer"},{"key":"1293_CR21","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1016\/S1470-2045(24)00075-5","volume":"25","author":"C Lynch","year":"2024","unstructured":"Lynch, C., Pitroda, S. P. & Weichselbaum, R. R. Radiotherapy, immunity, and immune checkpoint inhibitors. Lancet Oncol. 25, e352\u2013e362\u00a0(2024).","journal-title":"Lancet Oncol."},{"key":"1293_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI67313","volume":"124","author":"L Deng","year":"2014","unstructured":"Deng, L. et al. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J. Clin. Invest. 124, 687\u2013695 (2014).","journal-title":"J. Clin. Invest"},{"key":"1293_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijrobp.2020.01.030","volume":"108","author":"SN Seyedin","year":"2020","unstructured":"Seyedin, S. N. et al. Combination therapy with radiation and PARP inhibition enhances responsiveness to anti-PD-1 therapy in colorectal tumor models. Int. J. Radiat. Oncol. Biol. Phys. 108, 81\u201392 (2020).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1293_CR24","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","volume":"15","author":"MZ Dewan","year":"2009","unstructured":"Dewan, M. Z. et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin. Cancer Res. 15, 5379\u20135388 (2009).","journal-title":"Clin. Cancer Res."},{"key":"1293_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41571-023-00782-x","volume":"20","author":"L Galluzzi","year":"2023","unstructured":"Galluzzi, L., Aryankalayil, M. J., Coleman, C. N. & Formenti, S. C. Emerging evidence for adapting radiotherapy to immunotherapy. Nat. Rev. Clin. Oncol. 20, 543\u2013557 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1293_CR26","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","volume":"377","author":"SJ Antonia","year":"2017","unstructured":"Antonia, S. J. et al. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer.  N. Engl. J. Med. 377, 1919\u20131929 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1293_CR27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1200\/JCO.21.01308","volume":"40","author":"DR Spigel","year":"2022","unstructured":"Spigel, D. R. et al. Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. J. Clin. Oncol. 40, 1301\u20131311 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1293_CR28","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1200\/JCO-25-00036","volume":"43","author":"JD Bradley","year":"2025","unstructured":"Bradley, J. D. et al. Simultaneous durvalumab and platinum-based chemoradiotherapy in unresectable stage III non-small cell lung cancer: the phase III PACIFIC-2 study. J. Clin. Oncol. 43, 3610\u20133621 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1293_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1470-2045(21)00658-6","volume":"23","author":"JD Schoenfeld","year":"2022","unstructured":"Schoenfeld, J. D. et al. Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial. Lancet Oncol. 23, 279\u2013291 (2022).","journal-title":"Lancet Oncol."},{"key":"1293_CR30","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","volume":"71","author":"BC Burnette","year":"2011","unstructured":"Burnette, B. C. et al. The efficacy of radiotherapy relies upon induction of type\u00a0I interferon-dependent innate and adaptive immunity. Cancer Res. 71, 2488\u20132496 (2011).","journal-title":"Cancer Res."},{"key":"1293_CR31","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1158\/0008-5472.CAN-15-3142","volume":"77","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy. Cancer Res. 77, 839\u2013850 (2017).","journal-title":"Cancer Res."},{"key":"1293_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-01224-3","volume":"8","author":"Y Long","year":"2023","unstructured":"Long, Y. et al. GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer. Signal Transduct. Target. Ther. 8, 48 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1293_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev-pathol-031920-093932","volume":"16","author":"GM Boukhaled","year":"2021","unstructured":"Boukhaled, G. M., Harding, S. & Brooks, D. G. Opposing roles of type I interferons in cancer immunity. Annu. Rev. Pathol. 16, 167\u2013198 (2021).","journal-title":"Annu. Rev. Pathol"},{"key":"1293_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13046-021-01962-2","volume":"40","author":"RSA Goedegebuure","year":"2021","unstructured":"Goedegebuure, R. S. A. et al. Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation. J. Exp. Clin. Cancer Res. 40, 161 (2021).","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"1293_CR35","doi-asserted-by":"publisher","first-page":"D719","DOI":"10.1093\/nar\/gkab962","volume":"50","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res. 50, D719\u2013D728 (2022).","journal-title":"Nucleic Acids Res"},{"key":"1293_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m, A., Sayin, S. I., Marschall, H. U. & B\u00e4ckhed, F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24, 41\u201350 (2016).","journal-title":"Cell Metab."},{"key":"1293_CR37","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","volume":"62","author":"M Mueller","year":"2015","unstructured":"Mueller, M. et al. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity. J. Hepatol. 62, 1398\u20131404 (2015).","journal-title":"J. Hepatol."},{"key":"1293_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","volume":"35","author":"KN Lazaridis","year":"2001","unstructured":"Lazaridis, K. N., Gores, G. J. & Lindor, K. D. Ursodeoxycholic acid \u2018mechanisms of action and clinical use in hepatobiliary disorders\u2019. J. Hepatol. 35, 134\u2013146 (2001).","journal-title":"J. Hepatol."},{"key":"1293_CR39","doi-asserted-by":"crossref","unstructured":"Kim, M. J. et al. Ursodeoxycholate restores biliary excretion of methotrexate in rats with ethinyl estradiol induced-cholestasis by restoring canalicular Mrp2 expression. Int. J. Mol. Sci. 19, 1120 (2018).","DOI":"10.3390\/ijms19041120"},{"key":"1293_CR40","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey, E. J., Ali, A. H. & Lindor, K. D. Primary biliary cirrhosis. Lancet 386, 1565\u20131575\u00a0(2015).","journal-title":"Lancet"},{"key":"1293_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13046-020-01672-1","volume":"39","author":"A Oca\u00f1a","year":"2020","unstructured":"Oca\u00f1a, A. & Pandiella, A. Proteolysis targeting chimeras (PROTACs) in cancer therapy. J. Exp. Clin. Cancer Res.\u00a039, 189 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1293_CR42","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41573-021-00245-x","volume":"20","author":"M Schneider","year":"2021","unstructured":"Schneider, M. et al. The PROTACtable genome. Nat. Rev. Drug Discov. 20, 789\u2013797 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1293_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol"},{"key":"1293_CR44","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"1293_CR45","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA\u00a0102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1293_CR46","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon, J. A. et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 50, D165\u2013D173 (2022).","journal-title":"Nucleic Acids Res"},{"key":"1293_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"1293_CR48","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li, J. et al. The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling. Proteins 79, 2794\u20132812 (2011).","journal-title":"Proteins"},{"key":"1293_CR49","doi-asserted-by":"publisher","first-page":"W365","DOI":"10.1093\/nar\/gkx407","volume":"45","author":"Y Yan","year":"2017","unstructured":"Yan, Y., Zhang, D., Zhou, P., Li, B. & Huang, S. Y. HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy. Nucleic Acids Res. 45, W365\u2013W373 (2017).","journal-title":"Nucleic Acids Res."}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41422-026-01293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41422-026-01293-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41422-026-01293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:54:04Z","timestamp":1793829244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41422-026-01293-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["1293"],"URL":"https:\/\/doi.org\/10.1038\/s41422-026-01293-x","relation":{},"ISSN":["1748-7838"],"issn-type":[{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}